‡ In these countries please contact our distributor

Acticoat* Case Study MRomanelli VLU

Smith & Nephew logo


Acticoat Antimicrobial Barrier Dressing logo

Acticoat* 7 (with SILCRYST TM Nanocrystals) in the management of a venous leg ulcer

This case study demonstrates the use of Acticoat 7 in the management of a venous leg ulcer in a patient with diabetes.

The patient was a 71 year old male, treated at home for an ulcer located on the lower medial aspect of the leg. The ulcer had been present for two months. The ulcer had been previously dressed with a hydrocolloid dressing. At the beginning of treatment the wound measured 5cm x 9cm x 2mm. The wound was covered with 95% non-viable tissue and the surrounding skin was reddened and macerated. Exudate levels were small and no clinical signs of infection were detected (Fig.1).

The wound was cleansed and moistened Acticoat 7 was then applied. The Acticoat 7 was covered with moistened gauzes and dry gauzes on the top. Dressing changes were carried out every 7 days (Fig.2). Due to the diabetes and possibly an ischaemic component, compression therapy was not used.

After two weeks the wound was completely free of non-viable tissue. After 4 weeks the wound was completely healed (Fig.3).

Fig 1

Fig 2

Fig 3

Nanocrystalline Silver is a patented technology of NUCRYST Pharmaceuticals Corp.
TM SILCRYST is a trademark of NUCRYST Pharmaceuticals Corp, used under licence